Efficacy and safety of PL-5 (Peceleganan) spray for wound infections. A phase IIb randomized clinical trial.
Wei Y, Wu J, Yuxin C, Fan K, Yu X, Li X et al, on behalf of the PL-5 Investigators.
Ann Surg 2023; 277: 43-49.
This study examined the use of a new antimicrobial spray compared to silver sulphadiazine in 220 patients with a skin wound infection. Use of the spray at four varying doses all improved healing rates significantly (P<0.05).
Comment: This seems to be working more like an antiseptic.
22 March 2023